Revance Therapeutics announces change in role of Jacob Waugh, M.D.
Revance announced that Jacob Waugh, M.D. will relinquish his role as CSO, and consult on key programs while serving as an advisor to the CEO and the Science & Technology Committee of the Company's Board. July 02, 2015